Ea Series Trust Ironwood Pharmaceuticals Inc Transaction History
Ea Series Trust
- $2.84 Trillion
- Q2 2023
A detailed history of Ea Series Trust transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Ea Series Trust holds 18,407 shares of IRWD stock, worth $38,654. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,407Holding current value
$38,654% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
231Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$46.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$34.4 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$24.6 Million0.13% of portfolio
-
State Street Corp Boston, MA9.92MShares$20.8 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $322M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...